4//SEC Filing
CHANG LINDA L 4
Accession 0001123292-18-000508
CIK 0001360886other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 10:33 AM ET
Size
5.3 KB
Accession
0001123292-18-000508
Insider Transaction Report
Form 4
CHANG LINDA L
Chief Financial Officer
Transactions
- Award
Incentive Stock Option (right to buy)
2018-03-06+10,000→ 30,000 totalExercise: $8.95From: 2019-03-06Exp: 2028-03-05→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option shall vest on each of March 06, 2019, March 06, 2020, March 06, 2021 and March 06, 2022, subject to Reporting Person's continued service through the applicable vesting date.
Documents
Issuer
OSIRIS THERAPEUTICS, INC.
CIK 0001360886
Entity typeother
Related Parties
1- filerCIK 0001535179
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 10:33 AM ET
- Size
- 5.3 KB